Among the keys to deciphering normal physiological processes and their derangements in neoplasia are an understanding of the relationship in spatial and temporal terms of different cellular components to each other, and the related ability to correlate structure with function. Providing these capabilities of visualization is the goal of the KCC Bioimaging Facility/Shared Resource by having available powerful, reliable, and readily accessible light microscopic image acquisition and analysis capabilities for KCC investigators. The Facility is Cancer Center-managed and operates with well-trained staff and a faculty supervisor. Dr. James Keen, and provides training in operation of all instruments as well as consultation in operation, methodology, experimental approach, and interpretation. It is open for scheduled use at any time by trained investigators, or the Facility operator can perform imaging and analysis with laboratory personnel. Through the operation of this Shared Resource, individual KCC investigators are assured of state-of-the-art and reliable facilities operated with a high degree of technical expertise, and are relieved of the obligation for substantial outlay for equipment, maintenance and personnel training. The facility has provided service for more than 90 laboratories and several hundred individuals during the past award period, of which more than 80% are Cancer Center members. Major support for the Facility has been derived from successful competition for extramural funding, from institutional and Cancer Center sources, and from user chargebacks tied to services rendered.

Public Health Relevance

The Kimmel Cancer Center Bioimaging Facility provides investigators with the capability to visualize cells and structures within living and fixed cells at the light microscope level. By being able to determine the location and distribution of cellular components in time and space in normal and neoplastic samples, investigators can gain new information about how cancer cells differ from normal ones, and test hypotheses about cancer causation and progression.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
2P30CA056036-14
Application #
8517963
Study Section
Subcommittee G - Education (NCI)
Project Start
1997-07-15
Project End
2018-05-31
Budget Start
2013-06-18
Budget End
2014-05-31
Support Year
14
Fiscal Year
2013
Total Cost
$42,162
Indirect Cost
$14,938
Name
Thomas Jefferson University
Department
Type
DUNS #
053284659
City
Philadelphia
State
PA
Country
United States
Zip Code
19107
Peng, Weidan; Furuuchi, Narumi; Aslanukova, Ludmila et al. (2018) Elevated HuR in Pancreas Promotes a Pancreatitis-Like Inflammatory Microenvironment That Facilitates Tumor Development. Mol Cell Biol 38:
Waldman, Scott A; Camilleri, Michael (2018) Guanylate cyclase-C as a therapeutic target in gastrointestinal disorders. Gut 67:1543-1552
Sullivan-Reed, Katherine; Bolton-Gillespie, Elisabeth; Dasgupta, Yashodhara et al. (2018) Simultaneous Targeting of PARP1 and RAD52 Triggers Dual Synthetic Lethality in BRCA-Deficient Tumor Cells. Cell Rep 23:3127-3136
Lu, Huimin; Bowler, Nicholas; Harshyne, Larry A et al. (2018) Exosomal ?v?6 integrin is required for monocyte M2 polarization in prostate cancer. Matrix Biol 70:20-35
Lapadula, Dominic; Farias, Eduardo; Randolph, Clinita E et al. (2018) Effects of Oncogenic G?q and G?11 Inhibition by FR900359 in Uveal Melanoma. Mol Cancer Res :
Vite, Alexia; Zhang, Caimei; Yi, Roslyn et al. (2018) ?-Catenin-dependent cytoskeletal tension controls Yap activity in the heart. Development 145:
McNair, Christopher; Xu, Kexin; Mandigo, Amy C et al. (2018) Differential impact of RB status on E2F1 reprogramming in human cancer. J Clin Invest 128:341-358
Garcia, Samantha A; Lebrun, Aurore; Kean, Rhonda B et al. (2018) Clearance of attenuated rabies virus from brain tissues is required for long-term protection against CNS challenge with a pathogenic variant. J Neurovirol 24:606-615
Vido, Michael J; Le, Kaitlyn; Hartsough, Edward J et al. (2018) BRAF Splice Variant Resistance to RAF Inhibitor Requires Enhanced MEK Association. Cell Rep 25:1501-1510.e3
Brody, Jonathan R; Dixon, Dan A (2018) Complex HuR function in pancreatic cancer cells. Wiley Interdiscip Rev RNA 9:e1469

Showing the most recent 10 out of 807 publications